Dr. James Berenson helps patients understand new FDA recommendations regarding the use of lenalidomide (Revlimid) and a study from Sweden regarding increased risk of blot clots for myeloma patients. Dr. Berenson also previews the topics that he believes will be important for patients at the upcoming ASCO conference.
Understanding Myeloma News About Secondary Cancers and Clotting
May 28, 2012
Subscribe to our e-mail newsletter to receive updates.